| abstract |
A method of treatment of a condition where inhibition of thrombin is required, where the method comprises administration of a therapeutically effective amount of a compound of formula I: R1O(O)C-H2-(R)Cgl-Aze-Pab-R2 And the variables in formula I are described in the specification. The condition to be treated may be thrombosis, hypercoagulability in blood and tissues, Alzheimer's disease, idiopathic and adult respiratory distress syndrome and pancreatitis. (62) Divided out of 324902 |